Concentrix (CNXC) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue and profit exceeded guidance, driven by strong AI adoption, consolidation wins, and cross-selling, with GenAI platforms deployed at scale and early monetization of iX Hello AI suite; top 25 clients outpaced the rest in revenue growth.

• Net income increased 34.9% to $70.3M, with operating income up 13.8% to $168.9M and operating margin improving to 7.1%; non-GAAP diluted EPS rose 8.6% to $2.79.

• Durable recurring revenue streams, robust cash flow, and strong client relationships underpin confidence in long-term growth; over $240M expected to be returned to shareholders in FY25.

• Integration of Webhelp completed in September 2023, with ongoing synergy savings and continued investment in GenAI and digital transformation solutions.

• Guidance for 2025 remains conservative, with no macroeconomic improvement assumed and continued focus on operational efficiencies.

Financial highlights

• Q1 2025 revenue was $2.372 billion, down 1.3% year-over-year as reported but up 1.3% in constant currency, exceeding guidance.

• Non-GAAP operating income was $322 million (13.6% margin), up 0.8% year-over-year; adjusted EBITDA was $374.2 million (15.8% margin), down 2.6% year-over-year.

• Net income was $70.3 million, GAAP EPS $1.04; non-GAAP diluted EPS $2.79, up nearly 9% year-over-year.

• Adjusted free cash flow was a use of $39.8 million in Q1, reflecting seasonality, with strong cash generation expected from Q2.

• $48 million returned to shareholders in Q1 via $26 million in share repurchases and $22 million in dividends.

Outlook and guidance

• Q2 2025 revenue expected at $2.37–$2.39 billion, with constant currency growth of 0.5%–1.25%; Q2 non-GAAP EPS guidance: $2.69–$2.80.

• Full-year 2025 revenue guidance: $9.49–$9.635 billion, with constant currency growth of 0%–1.5%; non-GAAP EPS: $11.18–$11.77.

• Adjusted free cash flow projected at $625–$650 million for FY25; shareholder returns for FY25 expected to exceed $240 million.

• Dividend yield at 3% as of February 28, 2025; quarterly dividends expected to continue, subject to board approval.

• Guidance remains conservative, with no macroeconomic improvement assumed and ongoing FX headwinds.